FDA Rejects MDMA-Assisted Therapy for PTSD: What’s Next for Psychedelic Medicine?
After years of groundbreaking clinical trials and high expectations from both the medical and psychedelic research communities, Lykos Therapeutics has received a disappointing response...
America’s Behavioral Health Workforce Crisis: A Look at the Challenges and Solutions in Psychiatry
America is facing an increasingly dire behavioral health workforce crisis. Despite the rising demand for mental health services, the system is struggling to meet...
LifeStance: A Measured Approach to Growth in Mental Health Care
In an industry where aggressive expansion is often seen as the key to success, LifeStance Health (Nasdaq: LFST) is taking a decidedly more cautious...
Recovery Centers of America Reworks Leadership to Better Align with Regional Needs: A Strategic Shift for Improved Addiction Treatment Services
In a strategic move designed to enhance service delivery and improve operational efficiency, Recovery Centers of America (RCA), a premier addiction treatment provider based...
Private Equity in Behavioral Health: Shifting Dynamics and Opportunities for 2024 and Beyond
As we enter the second half of 2024, there’s growing optimism in the private equity (PE) community regarding the future of healthcare investments. While...
Talkspace’s Strategic Expansion into Government-Paid Mental Health Services: A Bold New Frontier
Talkspace, the leading virtual mental health provider (Nasdaq: TALK), is stepping into new and uncertain waters with its latest strategy: expanding its services to...
